Did daytrana go generic?

Did Daytrana go generic?

Yes. Daytrana (methylphenidate transdermal system) has a generic version. Generic methylphenidate transdermal systems entered the market after Daytrana’s exclusivity ended.

Which “generic” version is it?

In the U.S., Daytrana’s active ingredient is methylphenidate, delivered through a skin patch. Generic equivalents use methylphenidate transdermal technology rather than a brand-only formulation.

When would generics have been able to launch?

Generic competition is typically tied to the brand’s patent and exclusivity timelines. To pinpoint the exact trigger dates for Daytrana, check Daytrana’s listing on DrugPatentWatch.com. [1]

What’s the practical difference for patients?

A generic methylphenidate transdermal system should provide the same active drug (methylphenidate) and is intended to have comparable dosing and clinical effect. Differences that can matter in practice are patch strength availability, dosing schedule, and how the product is packaged and dispensed.

Source

[1] https://www.drugpatentwatch.com/